title: [Arsenic trioxide induced leukemic cell apoptosis relative to NF-kappaB activation].
abstract: To investigate the relationship of As(2)O(3)-induced leukemic cell apoptosis with NF-kappaB activation and expression of VEGF, MMP9, apoptosis of K562-n cells induced by As(2)O(3) was analyzed by Annexin V, the dynamic changes of NF-kappaB, MMP9 and VEGF expressions were detected by immunohistochemistry. The results showed that activity of NF-kappaB could be increased, accompanied by higher level of expression of MMP9 and VEGF when apoptosis of K562-n cells was induced by As(2)O(3). Dexamethasome not only increased significantly the apoptotic rate, but also suppressed the activation of NF-kappaB of K562-n cells induced by As(2)O(3). Furthermore, there was a positive correlation between the expression of MMP9, VEGF and the activity of NF-kappaB. It is concluded that As(2)O(3) can induce apoptosis, in the meanwhile, activate NF-kappaB and up-regulate expression of MMP9 and VEGF in K562-n cell line. The mechanism of apoptosis of K562-n cells enhanced by dexamethasome may be related to suppression of the activation of NF-kappaB and expression of MMP9 and VEGF.
authors.affiliation: Department of Hematology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China. xpxu1111@163.com
authors.forename: Xiao-Ping
authors.initials: XP
authors.lastname: Xu
authors.forename: Xiao-Wei
authors.initials: XW
authors.lastname: Xu
authors.forename: Ke
authors.initials: K
authors.lastname: Yi
authors.forename: Li
authors.initials: L
authors.lastname: Chen
authors.forename: Shao-Yi
authors.initials: SY
authors.lastname: Chen
authors.forename: Fang
authors.initials: F
authors.lastname: Zhou
authors.forename: Qian-Yu
authors.initials: QY
authors.lastname: Li
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology*; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D020014:K562 Cells; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D010087:Oxides / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D016328:NF-kappa B; D010087:Oxides; D042461:Vascular Endothelial Growth Factor A; D020780:Matrix Metalloproteinase 9; D000077237:Arsenic Trioxide